Drug intelligence / Profile preview

human-like collagen peptide

Development stage
Preclinical
Lead developer
Shanxi Jinbo Bio-Pharmaceutical
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

**Human-like collagen peptide** is a recombinant biomaterial developed by **JNU Biopharmaceutical Group** (also known as 暨大生物). It is produced using genetic engineering techniques, typically through microbial fermentation in hosts such as *E. coli* or yeast, to express peptide sequences that mimic the structural and biological properties of human collagen. Unlike animal-derived collagen, this recombinant peptide is designed to minimize immunogenicity and the risk of pathogen transmission while maintaining high biocompatibility. It functions as a bioactive scaffold and signaling molecule, interacting with cell-surface receptors like integrins to promote fibroblast adhesion, migration, and proliferation. Its primary applications include wound healing, skin repair, and medical aesthetics, where it facilitates the regeneration of the extracellular matrix and accelerates tissue recovery.

Other names
类人胶原肽Recombinant human-like collagen peptide
02

Targets

ITGA2/ITGB1 (Integrin alpha-2/beta-1 receptor)α10β1 (Integrin alpha 10 beta 1)

Beyond the preview

Go deeper on human-like collagen peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human-like collagen peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call